Acute pancreatitis and diabetic ketoacidosis in a schizophrenic patient taking olanzapine

Journal of Clinical Psychopharmacology

Volumn 27, Issue 4, 2007, Pages 397-400

  Kahn, Debra ^a   Bourgeois, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ARIPIPRAZOLE; GLIBENCLAMIDE; GLUCOSE; INSULIN; OLANZAPINE; WARFARIN;

ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DELIRIUM; DIABETIC KETOACIDOSIS; DRUG WITHDRAWAL; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; HEMATOCHEZIA; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; INTUBATION; LABORATORY TEST; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SELF MEDICATION; VOMITING;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COCAINE-RELATED DISORDERS; DIABETIC KETOACIDOSIS; HUMANS; KIDNEY FAILURE, ACUTE; MALE; PANCREATITIS; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 34447503524     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000264990.93652.80     Document Type: Article

References (19)

1. Koller EA, Cross JT, Doraiswamy PM, et al. Pancreatitis associated with atypical antipsychotics: from the food and drug administration's MEDWATCH surveillance system and published reports. Pharmacotherapy. 2003;23(9):1123-1130.
2. Doucett DE, Sylain Grenier JPM, Robertson PS. Olanzapine-induced pancreatitis. Ann Pharmacother. 2000;24:1128-1130.
3. Hagger R, Brown C, Hurley P. Olanzapine and pancreatitis. Br J Psychiatry. 2000;177:567.
4. Waage C, Carlsson H, Nielsen EW. Olanzapine-induced pancreatitis: a case report. JOP. 2004;5(5):388-391.
5. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39(8):709-719.
6. Ragucci KR, Wells BJ. Olanzapine-induced diabetic ketoacidosis. Ann Pharmacother. 2001;35:1556-1558.
7. Lee SP, Nichols JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med. 1992;326:589.
8. Melkersson KI, Hulting A-L, Brismar KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry. 2000;61:742-749.
9. Casey DE. Dyslipidemia and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65(suppl 18):27-35.
10. Koro CE, Fedder DO, L'Italien GJ, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry. 2002;59:1021-1026.
11. Meyer JM. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry. 2002;11:425-433.
12. Gupta S, Steinmeyer C, Frank B, et al. Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy. Am J Ther. 2003;10:348-355.
13. Havel RJ. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med. 1969;14:117-154.
14. Nagai H, Henrich H, Wunsch PH, et al. Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology. 1989;96:838-847.
15. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783.
16. Nair S, Yadav D, Pitchumoni CS. Association of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKA. Am J Gastroenterol. 2000;95(10):2795-2800.
17. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596-601.
18. Brunzell JD, Porte D Jr, Bierman EL. Abnormal lipoprotein lipase mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism. 1979;28:901-907.
19. Reaven GM, Greenfield MS. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes. 1981;4:343-348.